About this trial
Background: recurrent acute tonsillitis (RT) is a frequent condition affecting teenagers and adults. Patients suffer from recurring throat symptoms, fever and impaired quality of life (QOL). Tonsillectomy (TE) is the only well-known treatment, but studies indicate that tonsillotomy (TO) is associated with less morbidity (eg. pain and bleeding) and equal efficiency (e.g. reduced number of sore throat episodes and improved QOL). The investigator aim to clarify whether TO is a non-inferior alternative to TE.
Methods: inclusion and randomization of 250 adult RT patients for TE or TO with a 12 month follow up. Comparisons will be made between groups, and outcome measures includes number of sore throat episodes, QOL and postoperative pain.
Discussion: the study has the potential to improve the treatment of a prevalent disease by enhancing knowledge of an alternative procedure (TO) associated with less discomfort and risk than the current standard procedure (TE) and a presumably low risk of insufficiency.
Eligibility criteria
Qualifiers
Adults (age ≥15 years) with RT, defined as a minimum of five tonsillitis episodes in one year or a minimum of three tonsillitis episodes per year for two years (Danish National Guidelines criteria
The ability to understand Danish orally and in writing.
Disqualifiers
Previous TE or TO.
Suspected tonsillar malignancy.
History of malignant tumor in the oral cavity, the pharynx or the larynx.
Previous radiation therapy on head or neck.
Trial design
Treatments tested in this trial
- Tonsillotomy
- Tonsillectomy
Treatment groups
Sponsors and collaborators
Tejs Ehlers Klug
Lead sponsor
Aarhus University Hospital
Sponsor institution
University of Aarhus
Collaborator